MARLE GROUP acquired by THE CARLYLE GROUP

Marle Group is a world-leading strategic partner and contract development and manufacturing organization (CDMO) dedicated exclusively to the orthopedic and traumatology industry. Headquartered in France, the company provides a complete, vertically integrated value chain—from initial R&D and design assistance to forging, casting, precision machining, specialized coating, and final sterile packaging. Its business model is built on high-precision industrial expertise, supporting global Original Equipment Manufacturers (OEMs) in the production of hip, knee, shoulder, and spine implants, as well as extremity and trauma devices. The organization operates several state-of-the-art production facilities across Europe and the United States, maintaining the most stringent international regulatory certifications (ISO 13485, FDA). Strategically, the firm acts as a mission-critical consolidator in the MedTech supply chain, benefiting from the structural growth in joint replacement surgeries driven by aging global populations and active lifestyles. Its value proposition is centered on "one-stop-shop" efficiency, technical mastery of biocompatible materials, and a commitment to accelerating the time-to-market for innovative surgical solutions.